KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Illumina (ILMN) Research & Development (2016 - 2025)

Illumina (ILMN) has disclosed Research & Development for 17 consecutive years, with $239.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Research & Development fell 6.64% year-over-year to $239.0 million, compared with a TTM value of $967.0 million through Dec 2025, down 17.56%, and an annual FY2025 reading of $967.0 million, down 17.28% over the prior year.
  • Research & Development was $239.0 million for Q4 2025 at Illumina, up from $229.0 million in the prior quarter.
  • Across five years, Research & Development topped out at $486.0 million in Q1 2023 and bottomed at $197.0 million in Q2 2021.
  • Average Research & Development over 5 years is $298.1 million, with a median of $314.0 million recorded in 2023.
  • The sharpest move saw Research & Development soared 153.49% in 2021, then dropped 29.84% in 2023.
  • Year by year, Research & Development stood at $436.0 million in 2021, then fell by 25.0% to $327.0 million in 2022, then grew by 4.28% to $341.0 million in 2023, then fell by 24.93% to $256.0 million in 2024, then decreased by 6.64% to $239.0 million in 2025.
  • Business Quant data shows Research & Development for ILMN at $239.0 million in Q4 2025, $229.0 million in Q3 2025, and $247.0 million in Q2 2025.